Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile

MLA

Mingjun Zheng, et al. “Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile.” International Journal of Molecular Sciences, vol. 21, no. 23, Dec. 2020, p. 9169. EBSCOhost, https://doi.org/10.3390/ijms21239169.

APA

Mingjun Zheng, Heather Mullikin, Anna Hester, Bastian Czogalla, Helene Heidegger, Theresa Vilsmaier, Aurelia Vattai, Anca Chelariu-Raicu, Udo Jeschke, Fabian Trillsch, Sven Mahner, & Till Kaltofen. (2020). Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile. International Journal of Molecular Sciences, 21(23), 9169. https://doi.org/10.3390/ijms21239169

Chicago

Mingjun Zheng, Heather Mullikin, Anna Hester, Bastian Czogalla, Helene Heidegger, Theresa Vilsmaier, Aurelia Vattai, et al. 2020. “Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile.” International Journal of Molecular Sciences 21 (23): 9169. doi:10.3390/ijms21239169.